Now I have sufficient calibration context. Let me synthesize the final review.

## Summary

The paper introduces SELFIES-TED, a BART-style encoder-decoder transformer pretrained on SELFIES string representations of molecules. The model is trained on up to 1B molecule samples (ZINC-22 + PubChem) and evaluated on 10 MoleculeNet benchmarks for property prediction and on standard molecule generation metrics. The authors also propose a Multi-View Representation (MVR) approach that concatenates latent representations from multiple randomized SELFIES enumerations of the same molecule, and demonstrate molecule optimization via latent space perturbation.

## Strengths

- **Comprehensive empirical evaluation:** The paper evaluates on 10 MoleculeNet benchmarks (6 classification, 4 regression) plus 12 QM9 properties and standard molecule generation metrics, comparing against a wide range of baselines (graph-based, geometry-based, and string-based models). This is a broad and thorough evaluation scope.

- **Competitive benchmark results:** SELFIES-TED_large achieves top or near-top results on several datasets (e.g., BBBP 95.2, ClinTox 96.9, ESOL 0.454, FreeSolv 1.147), outperforming established models like MolFormer-XL on some tasks.

- **Dual capability for representation and generation:** Unlike most encoder-only molecular transformers, the encoder-decoder architecture supports both property prediction (via encoder embeddings) and molecule generation (via the decoder) within a single model. The generation evaluation (Table 6, Figures 5-6) goes beyond pure prediction tasks.

- **Multi-View Representation idea:** The observation (Figure 3) that enumerated SELFIES strings cluster in latent space, and that selectively combining their representations can improve downstream performance (Table 5, e.g., ClinTox ↑ from 96.90 to 97.51 at k=3), is an interesting empirical finding that leverages the inherent non-uniqueness of string representations.

## Weaknesses

### Major

- **No ablation studies to support architectural claims:** The paper repeatedly attributes performance gains to the use of SELFIES over SMILES and to the encoder-decoder architecture over encoder-only models (e.g., "training on SELFIES instead of SMILES ensures that the encoder output represents only valid molecules, enhancing the robustness"; "the encoder-decoder structure… provides better molecular representations"). However, there is **no controlled ablation**: no SELFIES-TED trained on SMILES with identical capacity and data, and no encoder-only variant trained on SELFIES. Without these, the paper cannot causally attribute gains to the choice of representation or architecture — only to the composite system of a particular model trained at particular scale. This is the central mechanistic claim of the paper, and it is unsupported by evidence.

- **Unfair baseline comparison due to different evaluation protocols:** For property prediction, SELFIES-TED uses **frozen encoder embeddings + XGBoost with extensive Optuna hyperparameter tuning**, while the baseline results are taken from original papers that typically used simple fine-tuning or linear/MLP heads. The paper does not state or control for the evaluation protocol of each baseline. On small datasets where XGBoost with heavy tuning can be very strong, this creates a structural advantage unrelated to representation quality. The "state-of-the-art" claims rest on this asymmetric protocol. Without re-evaluating baselines under the same frozen-features + XGBoost setup, or showing SELFIES-TED results under standard fine-tuning, the comparison is not apples-to-apples.

- **MVR method is underspecified and the greedy selection procedure is opaque:** The "greedy selection process" for choosing which latent views to concatenate (Section 3) is never formally defined. Critical details are missing: What objective function does the greedy selection optimize? Is selection performed per dataset, per fold, or per molecule? Is validation data used for selection, and if so, how is overfitting avoided given 31 combinations and small datasets? Without an explicit algorithm, MVR is not reproducible, and the improvements in Table 5 may reflect overfitting to the evaluation split rather than a principled enrichment. Additionally, the table shows that some k values *degrade* performance (e.g., ClinTox drops from 96.90 at k=1 to 85.27 at k=4), undermining the claim that MVR consistently improves representations — yet this fragility is not discussed.

### Minor

- **No variance or significance reporting:** All results in Tables 2–5 are reported as point estimates with no standard deviations, confidence intervals, or statistical significance tests. On small datasets (BACE n=1,513; ClinTox n=1,478; FreeSolv n=642), performance can vary substantially across seeds, especially with aggressive hyperparameter tuning. Without variance estimates, it is unclear whether the reported differences from baselines are meaningful or within noise.

- **QM9 "Overall MAE" is not a meaningful aggregate metric:** Table 4 reports an "Overall MAE" obtained by summing per-target MAEs across 12 QM9 properties with wildly different scales (e.g., ⟨R²⟩ ≈ 38.8 vs. gap ≈ 0.008). Summing these is not principled; a single large-scale property can dominate the aggregate. The per-target results are shown, which partially mitigates this, but the headline comparison based on overall MAE (4.263 vs. 5.069 vs. 8.707) is misleading.

- **Generation evaluation protocol differs from baselines:** Table 6 compares SELFIES-TED against baselines (CharRNN, VAE, etc.) whose metrics come from Bagal et al. (2021) using the MOSES protocol. However, SELFIES-TED generates molecules by randomly perturbing encoder latent representations of 10,000 reference molecules from ZINC+PubChem, which is a different generation setup than unconditional sampling from a learned prior. This makes FCD, novelty, and uniqueness metrics not directly comparable to baselines trained/evaluated under MOSES. The paper does not clarify whether the reference set matches MOSES's training set.

- **Confusing pretraining data description:** The small model (2.2M params) is pretrained on 8B samples and the large model (358M params) on 1B samples. This is counterintuitive — the larger model trains on less data — and the paper's narrative attributes performance gains to "extensive pretraining" and "increased diversity" without addressing this disparity. The abstract claims only "1 billion molecule samples," which obscures the small model's 8B training. This hinders interpretation of scaling effects.

- **Introduction contains a misleading claim:** The paper states "most existing transformer models for material informatics are encoder-only models, which are not capable of generating new molecules." This is inaccurate — encoder-only models can be combined with separate generative heads, and existing generative molecular models (e.g., MolGPT, which the paper cites) already demonstrate this. The real distinction is architectural convenience, not fundamental capability.

### Trivial

- The "SELFIES-TED (w/ canonical)" row in Table 5 is introduced without explanation — it is unclear what this condition means (a different canonical SELFIES? a different model? fine-tuned?).

## Nice-to-Haves

- Ablation comparing SELFIES-TED (encoder-decoder) vs. an encoder-only model of the same capacity trained on the same data, and SELFIES vs. SMILES as input representation with the same architecture.
- End-to-end fine-tuning results for SELFIES-TED on downstream tasks, to establish whether the strong XGBoost results are primarily due to representation quality or the downstream model.
- MVR evaluated with simple baselines (e.g., mean-pooling of k representations rather than greedy concatenation) to isolate the contribution of the selection strategy.
- Latent space interpolation analysis showing smooth property transitions between real molecules, rather than only global t-SNE visualizations.

## Removed Points

- **Training detail reproducibility (batch size, learning rate, schedule, convergence curves):** The harsh critic and neutral reviewer both flagged missing training details. While these details would be helpful, they fall under reproducibility nitpicks that are impractical to include fully in a submission. The model architecture, pretraining objective, and datasets are specified, which is sufficient for the paper's claims. (These are routine missing details in many ML papers and are not fatal.)

- **Demand for code and model checkpoints:** Requesting release of code/checkpoints is a nice-to-have, not a substantive weakness.

- **Novelty=1.0 in generation is suspicious:** The spark reviewer suggested this might indicate distribution shift. While worth noting, validity=1.0 is expected for SELFIES-based generation (since SELFIES guarantees syntactic validity), and novelty=1.0 means generated molecules are not in the reference set — this is plausible given the reference set is only 10K molecules from a vast chemical space. This is not necessarily a red flag.

- **Missing recent baselines (e.g., additional 3D GNN models on QM9):** The paper already compares against a comprehensive set. Demanding more baselines is an endless treadmill.

- **Molecule generation optimization examples are cherry-picked (Figure 7):** While the 9 examples in Figure 7 are selected successes, the paper presents this as a "preliminary" analysis and does not make strong quantitative claims about optimization capability. Acknowledging this is preliminary is sufficient.

## Novel Insights

The most interesting finding that emerges across the reviews is the fragility of the MVR approach: while k=2 or k=3 improves some metrics, k=4 or k=5 actually degrades performance on ClinTox (from 96.90 to 85.27) and FreeSolv (from 1.147 to 1.279). This suggests that naive concatenation of more views is not always beneficial, and the greedy selection strategy may be overfitting to small validation sets rather than discovering genuinely informative representations. The paper's narrative of MVR as "enriching" representations would be more convincing with a systematic analysis of when and why additional views hurt performance.

## Suggestions

- **Run a controlled ablation:** Train an encoder-only variant (e.g., BERT-style) with the same data and comparable parameters on SELFIES, and a BART model on SMILES. This would directly test the two central claims (SELFIES advantage; encoder-decoder advantage).

- **Re-evaluate baselines under a consistent protocol:** Either (a) apply the same frozen-features + XGBoost protocol to all baseline representations, or (b) show SELFIES-TED results under standard fine-tuning. This is essential for fair comparison.

- **Formally specify the greedy selection algorithm in MVR:** Provide pseudocode and clarify what data is used for selection. Compare against simple baselines like mean-pooling.

- **Report standard deviations across multiple seeds** for at least the key benchmarks.

- **Fix the Overall MAE** in Table 4 by using a normalized metric (e.g., mean rank or normalized MAE) instead of raw-sum across properties with different scales.

## Score and Decision

Calibration against similar papers:
- **SMI-TED** (Yq8At31hLi.md): A very similar BART-style molecular encoder-decoder using SMILES. Shared weaknesses (limited novelty, missing ablations, QM9 overall MAE issue, underspecified contributions). Scored 3-5, rejected/withdrawn. SELFIES-TED has somewhat more comprehensive evaluation and an additional MVR contribution, but also has worse evaluation fairness concerns.
- **MolGen** (9rPyHyjfwP.md): BART + SELFIES for molecule generation. Scored 6-8, accepted poster. Had a more novel contribution (self-feedback paradigm) and better experimental design. SELFIES-TED is a weaker version of this with less novelty.
- **FARM** (o2o1XNeI1b.md): Foundation model for molecules. Limited novelty, no ablations. Scored 3-5, rejected.
- **UniMoT** (Pgwpc0rzbM.md): Molecule-text model with some issues. Scored 3-6, rejected.

SELFIES-TED sits in the same space as SMI-TED and MolGen but with less novelty (no self-feedback mechanism like MolGen, no novel MoE architecture) and significant evaluation methodology concerns (asymmetric protocols, no ablations, underspecified MVR). It is comparable to SMI-TED in quality — perhaps slightly better due to broader evaluation, but fundamentally shares the same weaknesses. The paper makes ambitious claims ("state-of-the-art," architectural advantages) that are not supported by controlled experiments.

Score: **4** — The paper presents a competent engineering effort with reasonable benchmark coverage, but the core claims about SELFIES and encoder-decoder superiority are unverified, the evaluation protocol gives an unfair advantage over baselines, and the MVR contribution is underspecified. These issues collectively undermine the paper's central narrative without fatal flaws.

MY FINAL SCORE: <pineapple>4</pineapple>
MY FINAL DECISION: <orange>Reject</orange>